SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report
SEC Accession No. 0001193125-11-045608
Filing Date
2011-02-25
Accepted
2011-02-24 17:33:39
Documents
5
Period of Report
2011-02-22
Filing Date Changed
2011-02-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 28043
2 FORM OF WARRANT ISSUED TO INVESTORS dex41.htm EX-4.1 92205
3 PURCHASE AGREEMENT dex101.htm EX-10.1 211556
4 REGISTRATION RIGHTS AGREEMENT dex102.htm EX-10.2 152713
5 PRESS RELEASE dex991.htm EX-99.1 7062
  Complete submission text file 0001193125-11-045608.txt   493539
Mailing Address 21900 BURBANK BLVD. 3RD FLOOR WOODLAND HILLS CA 91367
Business Address 21900 BURBANK BLVD. 3RD FLOOR WOODLAND HILLS CA 91367 818-992-2907
ImmunoCellular Therapeutics, Ltd. (Filer) CIK: 0000822411 (see all company filings)

IRS No.: 931301885 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-17264-NY | Film No.: 11637682
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1